Defense World
26 Jul 2026, 05:59 UTC · 8w ago
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives $24.25 Consensus Target Price from Analysts
Verdict
Headline takes no side. We score ARCT +0.30 across four claims — moderately bullish.
- Expected · ARCT
+0.30moderately bullish
−1 bearish0bullish +1More positive than 58% of ticker scores this week
- Actual




